These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12360492)

  • 1. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.
    Canbay A; Higuchi H; Bronk SF; Taniai M; Sebo TJ; Gores GJ
    Gastroenterology; 2002 Oct; 123(4):1323-30. PubMed ID: 12360492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
    Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.
    Miyoshi H; Rust C; Roberts PJ; Burgart LJ; Gores GJ
    Gastroenterology; 1999 Sep; 117(3):669-77. PubMed ID: 10464144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
    Kahraman A; Barreyro FJ; Bronk SF; Werneburg NW; Mott JL; Akazawa Y; Masuoka HC; Howe CL; Gores GJ
    Hepatology; 2008 Apr; 47(4):1317-30. PubMed ID: 18220275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice.
    Ogawa A; Tagawa T; Nishimura H; Yajima T; Abe T; Arai T; Taniguchi M; Takeda K; Akira S; Nimura Y; Yoshikai Y
    Gut; 2006 Jan; 55(1):105-13. PubMed ID: 16118350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α7-nAChR Knockout Mice Decreases Biliary Hyperplasia and Liver Fibrosis in Cholestatic Bile Duct-Ligated Mice.
    Ehrlich L; O'Brien A; Hall C; White T; Chen L; Wu N; Venter J; Scrushy M; Mubarak M; Meng F; Dostal D; Wu C; Lairmore TC; Alpini G; Glaser S
    Gene Expr; 2018 Aug; 18(3):197-207. PubMed ID: 29580318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.
    Canbay A; Guicciardi ME; Higuchi H; Feldstein A; Bronk SF; Rydzewski R; Taniai M; Gores GJ
    J Clin Invest; 2003 Jul; 112(2):152-9. PubMed ID: 12865404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
    Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
    Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.
    Gujral JS; Liu J; Farhood A; Jaeschke H
    Hepatology; 2004 Oct; 40(4):998-1007. PubMed ID: 15382126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
    Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
    J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
    Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
    Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids.
    Lee S; Kim S; Le HD; Meisel J; Strijbosch RA; Nose V; Puder M
    J Pediatr Surg; 2008 Nov; 43(11):2010-5. PubMed ID: 18970933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H; Zhang Y; Heuckeroth RO
    Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.
    Moon JO; Welch TP; Gonzalez FJ; Copple BL
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G582-92. PubMed ID: 19136383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease.
    Mitchell C; Mahrouf-Yorgov M; Mayeuf A; Robin MA; Mansouri A; Fromenty B; Gilgenkrantz H
    Lab Invest; 2011 Feb; 91(2):273-82. PubMed ID: 20856227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.